Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-26T22:14:55.060Z Has data issue: false hasContentIssue false
  • English
  • Français

Rapid Improvement in Bipolar II Depression Induced by Low-Dose Lamotrigine Augmentation: Two Case Reports

Published online by Cambridge University Press:  07 November 2014

Omer Akil Ozer ,
Okan Ekinci  and
Ali Caykoylu
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters
Information
CNS Spectrums , Volume 15 , Issue 9 , September 2010 , pp. 599 - 601
Copyright
Copyright © Cambridge University Press 2010

References

1.Ghaemi, SN, Ko, JY, Goodwin, FK. “Cade's disease” and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002;47:125–134.CrossRefGoogle Scholar
2.Leverich, GS, Altshuler, LL, Frye, MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163:232–239.CrossRefGoogle ScholarPubMed
3.Altshuler, LL, Suppes, T, Black, DO, et al. Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second generation antidepressants. Am J Psychiatry. 2006;163:313–315.CrossRefGoogle ScholarPubMed
4.Homan, S, Lachenbruch, PA, Winkur, G, et al. An efficacy study of electroconvulsive therapy and antidepressants in the treatment of primary depression. Psychol Med. 1982;12:615–624.CrossRefGoogle ScholarPubMed
5.Himmelhoch, JM, Thase, ME, Mallinger, AG, et al. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry. 1991;148:910–916.Google ScholarPubMed
6.Thase, ME, Mallinger, AG, McKnight, D, et al. Treatment of imipramine-resistant recurrent depression, IV: a double- blind crossover study of tranylcypromine for anergic bipolar depression. Am J Psychiatry. 1992;149:195–198.Google Scholar
7.Young, LT, Joffe, RT, Robb, JC, et al. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry. 2000;157:124–126.CrossRefGoogle Scholar
8.Tohen, M, Vieta, E, Calabrese, J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60:1079–1088.CrossRefGoogle ScholarPubMed
9.Calabrese, JR, Keck, PE Jr, Macfadden, W, et al. (BOLDER Study Group): A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162:1351–1360.CrossRefGoogle ScholarPubMed
10.Sharma, V, Khan, M, Corpse, C. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review. J Affect Disord. 2008;111(1):100–105.CrossRefGoogle ScholarPubMed
11.Prica, C, Hascoet, M, Bourin, M. Antidepressant-like effect of lamotrigine is reversed by veratrine: a possible role of sodium channels in bipolar depression. Behav Brain Res. 2008;191(1):49–54.CrossRefGoogle ScholarPubMed
12.Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.CrossRefGoogle ScholarPubMed
13.Nierenberg, AA, Ostacher, MJ, Calabrese, JR, et al. Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. Am J Psychiatry. 2006; 163(2):210–216.CrossRefGoogle ScholarPubMed
14.Schaffer, A, Zuker, P, Levitt, A. Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression. J Affect Disord. 2006;96:95–99.CrossRefGoogle ScholarPubMed
15.Yatham, LN, Kennedy, SH, O'Donovan, C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guide-lines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 2006;8:721–739.CrossRefGoogle Scholar
16.Consoni, FT, Vital, MA, Andreatini, R. Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol. 2006;16(6):451–458.CrossRefGoogle ScholarPubMed
17.Kaster, MP, Raupp, I, Binfaré, RW, et al. Antidepressant-like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur J Pharmacol. 2007;565:119–124.CrossRefGoogle ScholarPubMed
18.Muck-Seler, D, Sagud, M, Mustapic, M, et al. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(5):1195–1198.CrossRefGoogle ScholarPubMed
19.Frye, MA, Watzl, J, Banakar, S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 2007;32(12):2490–2499.CrossRefGoogle ScholarPubMed
20.Ostroff, RB, Nelson, JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry. 1999;60:256–259.CrossRefGoogle ScholarPubMed
21.Parker, G. Olanzapine augmentation in the treatment of melancholia: the trajectory of improvement in rapid responders. Int Clin Psychopharmacol. 2002;17:87–89.CrossRefGoogle ScholarPubMed
22.De Montigny, C, Grunberg, F, Mayer, A, et al. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. Br J Psychiatry. 1981;138:252–256.CrossRefGoogle ScholarPubMed
23.Calabrese, JR, Huffman, RF, White, RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord. 2008;10(2):323–333.CrossRefGoogle ScholarPubMed
24.van der Loos, ML, Mulder, PG, Hartong, EG, et al. Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. J Clin Psychiatry. 2009;70(2):223–231.CrossRefGoogle ScholarPubMed
25.Ghaemi, SN, Schrauwen, E, Klugman, J, et al. Long-term lamotrigine plus lithium for bipolar disorder: One year outcome. J Psychiatr Pract. 2006;12(5):300–305.CrossRefGoogle ScholarPubMed
26.Leykin, Y, Amsterdam, JD, DeRubeis, RJ, et al. Progressive resistance to SSRI therapy but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol. 2007;75(2):267–276.CrossRefGoogle Scholar
27.Posternak, MA, Zimmerman, M. Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: A retrospective study. J Clin Psychiatry. 2005;66:705–707.CrossRefGoogle ScholarPubMed
28.Sharma, V. Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series. J Affect Disord. 2001;64(1):99–106.CrossRefGoogle ScholarPubMed
29.Sharma, V, Khan, M, Smith, A. A closer look at treatment resistant depression: is it due to a bipolar diathesis? J Affect Disord. 2005;84:251–257.CrossRefGoogle Scholar
30.Ei-Mallakh, RS, Karippot, A. Antidepressant-associated chronic irritable dysphoria (ACID) in bipolar disorder: a case series. J Affect Disord. 2005;84:267–272.CrossRefGoogle ScholarPubMed